Rethinking Evidence Strategy in HEOR Budget Planning

For many of those who focus on generating value propositions through HEOR, Fall is the time for budget planning for the upcoming fiscal year. With so many changes influencing the healthcare landscape, revisiting and advancing an organization's evidence needs is necessary to more accurately build an effective value-based commercialization strategy. The article, "Rethinking Evidence Strategy in HEOR Budget Planning," was authored by Nicole Betor, Nancy El Hoyek, Laura Housman, Josie Lloyd, and Taylor Schwartz.

To read the article, visit Pharma Focus America.

Learn More
Avalere leverages our staff's deep expertise in evidence generation planning, data partnership evaluation, and HEOR to help clients develop their annual research agendas and conceptualize studies that meet their business objectives. To explore how Avalere can partner with you to ensure your evidence generation strategies reflect current market trends and future business needs, connect with us.